Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Integrating Psychiatric Pharmacist Services Into a Rural Clinic Helps Patient Care, Staff Satisfaction
09/29/2022
“However, psychiatric pharmacist integration has not been widely utilized to full capacity at many rural, private institutions,” wrote study authors.
“However, psychiatric pharmacist integration has not been widely utilized to full capacity at many rural, private institutions,” wrote study authors.
“However, psychiatric pharmacist...
09/29/2022
Pharmacy Learning Network
News
Tablet Mix-Up Prompts Recall
09/29/2022
A Class III recall has been issued for a prescription medication used to treat hypertension.
A Class III recall has been issued for a prescription medication used to treat hypertension.
A Class III recall has been...
09/29/2022
Pharmacy Learning Network

Advertisement

News
Laxative Product Recalled Over Contamination Concerns
09/22/2022
Class I and Class II recalls have been issued for a slate of laxative products.
Class I and Class II recalls have been issued for a slate of laxative products.
Class I and Class II recalls...
09/22/2022
Pharmacy Learning Network
News
ACE Inhibitor Recalled by Two Firms
09/22/2022
Several lots of lisinopril are being recalled due to a fragment of metal found embedded in a tablet.
Several lots of lisinopril are being recalled due to a fragment of metal found embedded in a tablet.
Several lots of lisinopril are...
09/22/2022
Pharmacy Learning Network
News
Class I Recall for Anesthetic, Sedation Drug
09/22/2022
A general anesthetic and sedation drug is under a Class I recall due to presence of particulate matter.
A general anesthetic and sedation drug is under a Class I recall due to presence of particulate matter.
A general anesthetic and...
09/22/2022
Pharmacy Learning Network

Advertisement

News
Smartphone-Based Meditation App Reduces Stress, Improves Mindfulness Among Pharmacy Students
09/19/2022
Researchers investigated the effects of a smartphone-based meditation app on well-being, mindfulness, stress, and resilience among pharmacy students.
Researchers investigated the effects of a smartphone-based meditation app on well-being, mindfulness, stress, and resilience among pharmacy students.
Researchers investigated the...
09/19/2022
Pharmacy Learning Network
News
Antihistamine Recalled
09/15/2022
More than a half-million cups of an over-the-counter antihistamine are being recalled due to inadequately controlled manufacturing processes.
More than a half-million cups of an over-the-counter antihistamine are being recalled due to inadequately controlled manufacturing processes.
More than a half-million cups of...
09/15/2022
Pharmacy Learning Network
News
Pain Reliever Recalled
09/15/2022
A Class II recall has been issued for numerous lots of acetaminophen oral solution.
A Class II recall has been issued for numerous lots of acetaminophen oral solution.
A Class II recall has been...
09/15/2022
Pharmacy Learning Network

Advertisement

News
Microbial Contamination Prompts Class I Recall
09/15/2022
Plastikon Healthcare is voluntarily recalling medications used to treat constipation and other digestive conditions due to microbial contamination and inadequately controlled conditions.
Plastikon Healthcare is voluntarily recalling medications used to treat constipation and other digestive conditions due to microbial contamination and inadequately controlled conditions.
Plastikon Healthcare is...
09/15/2022
Pharmacy Learning Network
News
Vonoprazan vs PPIs for Treating Heartburn in Patients With Erosive Esophagitis
09/13/2022
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and...
09/13/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use